Free Trial
NASDAQ:JYNT

Joint 9/13/2023 Earnings Report

Joint logo
$11.45 -0.15 (-1.29%)
Closing price 04:00 PM Eastern
Extended Trading
$11.46 +0.01 (+0.09%)
As of 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Joint EPS Results

Actual EPS
-$0.01
Consensus EPS
$0.01
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Joint Revenue Results

Actual Revenue
$29.31 million
Expected Revenue
$29.85 million
Beat/Miss
Missed by -$540.00 thousand
YoY Revenue Growth
N/A

Joint Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Joint's Q2 2025 earnings is scheduled for Wednesday, August 6, 2025, with a conference call scheduled on Thursday, August 7, 2025 at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Joint Earnings Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
JYNT - The Joint Corp Key Metrics - Morningstar
See More Joint Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Joint? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Joint and other key companies, straight to your email.

About Joint

Joint (NASDAQ:JYNT), Inc. (NASDAQ: JYNT) operates a digital imaging and telemedicine platform tailored for the veterinary industry, providing on-demand diagnostic services to enhance patient care and clinical efficiency. The company’s core offerings include digital radiography, ultrasound, MRI and CT imaging, combined with cloud-based tele-interpretation services. By integrating with leading practice management systems, Joint streamlines scheduling, image acquisition and reporting, allowing veterinary practices to access board-certified radiologists and immediate diagnostic insights without the overhead of in-house imaging suites.

In addition to its teleradiology network, Joint deploys mobile imaging units staffed by trained technologists, enabling clinics across urban and rural markets to offer advanced diagnostics on-site. The company’s proprietary software delivers secure image transfer, automated quality checks and structured reporting, reducing turnaround times and improving case throughput. Joint also provides consulting services to help practices optimize equipment selection, workflow design and compliance protocols, positioning itself as an end-to-end partner for veterinary diagnostic expansion.

Founded in the late 2010s by a multidisciplinary team of veterinarians, software engineers and medical imaging experts, Joint has scaled its footprint throughout North America. It serves a broad spectrum of clinics—from single-doctor practices to regional referral centers—in all 50 states and parts of Canada. The company’s growth has been driven by strategic alliances with equipment manufacturers and practice management vendors, as well as targeted investments in network infrastructure and data analytics to support predictive care and population health management.

Joint’s executive leadership combines deep experience in veterinary medicine, digital health innovation and medical imaging. The management team focuses on product development, regulatory compliance and strategic partnerships to drive both organic growth and market expansion. As the veterinary sector continues to embrace telehealth and advanced diagnostics, Joint aims to extend its platform with AI-driven image analysis, expanded service lines and broader geographic coverage to meet evolving clinician and patient needs.

View Joint Profile

More Earnings Resources from MarketBeat